Invesco Ltd. Merck & Co., Inc. Transaction History

Invesco Ltd.

$453 Billion
Q1 2024

A detailed history of Invesco Ltd. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Invesco Ltd. holds 16,058,539 shares of MRK stock, worth $1.99 Billion. This represents 0.47% of its overall portfolio holdings.

Number of Shares

16,058,539

Previous 16,757,610 4.17%

Holding current value

$1.99 Billion

Previous $1.83 Billion 15.98%

% of portfolio

0.47%

Previous 0.44%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $79.2 Million - $92.2 Million	-699,071 Reduced 4.17%	16,058,539 $2.12 Billion
Q4 2023 Feb 12, 2024	SELL	$100.18 - $109.02 $91.7 Million - $99.8 Million	-915,207 Reduced 5.18%	16,757,610 $1.83 Billion
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $384 Million - $426 Million	-3,729,753 Reduced 17.43%	17,672,817 $1.82 Billion
Q2 2023 Aug 11, 2023	BUY	$108.61 - $118.38 $267 Million - $291 Million	2,455,377 Added 12.96%	21,402,570 $2.47 Billion
Q1 2023 May 12, 2023	BUY	$102.94 - $114.86 $106 Million - $118 Million	1,025,444 Added 5.72%	18,947,193 $2.02 Billion

Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $23.7 Million - $30.4 Million	270,778 Added 1.53%	17,921,749 $1.99 Billion
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $152 Million - $170 Million	-1,795,320 Reduced 9.23%	17,650,971 $1.52 Billion
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $50.2 Million - $56.9 Million	-600,853 Reduced 3.0%	19,446,291 $1.77 Billion
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $11.3 Million - $12.7 Million	-153,985 Reduced 0.76%	20,047,144 $1.64 Billion
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $53.5 Million - $67 Million	739,839 Added 3.8%	20,201,129 $1.55 Billion
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $408 Million - $448 Million	5,687,973 Added 41.3%	19,461,290 $1.46 Billion
Q2 2021 Aug 17, 2021	BUY	$70.31 - $77.77 $179 Million - $198 Million	2,551,921 Added 22.74%	13,773,317 $1.07 Billion
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $278 Million - $327 Million	-4,036,494 Reduced 26.46%	11,221,396 $865 Million
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $17.2 Million - $19.1 Million	-240,295 Reduced 1.55%	15,257,890 $1.25 Billion
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $68 Million - $77 Million	-928,865 Reduced 5.65%	15,498,185 $1.29 Billion
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $80.6 Million - $91.7 Million	-1,144,137 Reduced 6.51%	16,427,050 $1.27 Billion
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $40.1 Million - $55.6 Million	-633,251 Reduced 3.48%	17,571,187 $1.35 Billion
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $70.6 Million - $79.7 Million	-910,587 Reduced 4.76%	18,204,438 $1.66 Billion
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $61.3 Million - $66.8 Million	805,887 Added 4.4%	19,115,025 $1.61 Billion
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $199 Million - $232 Million	2,843,458 Added 18.39%	18,309,138 $1.54 Billion
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $311 Million - $355 Million	-4,467,903 Reduced 22.41%	15,465,680 $1.29 Billion
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $1.3 Billion - $1.51 Billion	19,933,583 New	19,933,583 $1.52 Billion

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account